We are excited to announce that Zhana Kuncheva, our Director of Health Data Science, recently published an insightful article in Pharma IQ titled “Unlocking Health Data’s Potential: The AI Revolution in Healthcare.” This article explores how artificial intelligence (AI) is transforming healthcare by unlocking the value hidden in vast data reserves, with a particular focus on drug discovery and patient care.
Zhana explains that the healthcare sector generates more than 30% of the world’s data, yet much of this data remains underutilised. She highlights how AI tools are essential for processing and interpreting this information at unprecedented speed and accuracy. She mentions notable advancements like AlphaFold, which predicts protein structures, and bioXcelerate’s own tool, PleioGraph. PleioGraph accelerates data analysis, identifying potential drug targets 100 times faster while reducing the risk of false leads.
Zhana also discusses how the AI revolution is reshaping drug discovery by enabling earlier diagnoses and better treatments. AI tools are helping researchers sift through massive datasets to identify disease pathways and predict health outcomes, leading to more precise, individualised medical care. This move toward personalised medicine promises to revolutionise patient care, offering tailored treatment plans based on a person’s unique genetic profile.
However, Zhana stresses that for AI to deliver on its potential, it must be built on accurate, comprehensive data and foster trust between clinicians, patients, and AI systems. With an ageing population and increasing disease diagnoses, the need for AI-driven healthcare solutions has never been more urgent.
Read the full article here to learn about how bioXcelerate AI is transforming the healthcare industry.